Fulvestrant Injection 250mg

Fulvestrant Injection 250mg

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Function Anti-Cancer
  • Dosage 250 Mg
  • Suitable For Adults
  • Supply Ability : 1 Piece Lac Per Week
  • Click to view more
X

Price And Quantity

  • 1 Lac Piece
  • 250 INR

Product Specifications

  • Anti-Cancer
  • Injection
  • Adults
  • 250 Mg
  • Liquid

Trade Information

  • Cash in Advance (CID), Cash Advance (CA)
  • 1 Piece Lac Per Week
  • 1 Week
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

Fulvestrant Injection 250mg

We are engaged in trading, exporting and supplying extremely effective Fulvestrant Injection 250mg. Offered injection is precisely processed using excellent grade chemical substances in compliance with set industry standards at our vendors’ end. This injection is given to the patients of breast cancer in order to block the effect of estrogen and to slow tumor cell growth. Further, we provide this Fulvestrant Injection 250mg in diverse packaging options at market leading price to the clients.

Features:

  • High effectiveness

  • Precise composition

  • Safe to use

  • Long shelf life

Detailed Description :

Faslodex is the trade name for Fulvestrant. In some cases, health care professionals may use the trade name Faslodex when referring to the generic drug name Fulvestrant.

Drug type:  Faslodex is a hormone therapy.  It fights cancer as an estrogen receptor down-regulator.

It is used to treat estrogen receptor positive metastatic breast cancer (cancer that has spread) in postmenopausal women, with disease progression following antiestrogen therapy. It is manufactured by AstraZeneca Pharmaceuticals


DHEER HEALTHCARE PRIVATE LIMITED

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.